Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure
<p>Abstract</p> <p>Background</p> <p>Signaling networks promoting cell growth and proliferation are frequently deregulated in cancer. Tumors often are highly dependent on such signaling pathways and may become hypersensitive to downregulation of key components within th...
Main Authors: | Rapp Ulf R, Götz Rudolf, Kramer Boris W |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/4/24 |
Similar Items
-
Use of a recombinant <it>Salmonella enterica </it>serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice
by: Troppmair Jakob, et al.
Published: (2005-02-01) -
Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression
by: Götz Rudolf
Published: (2008-05-01) -
A Role for K-ras in Conferring Resistance to the MEK Inhibitor, CI-1040
by: Yuli Wangab, et al.
Published: (2005-04-01) -
Advances of RAF and lung cancer
by: Zhuomin WANG, et al.
Published: (2008-06-01) -
Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer.
by: Matthias Becker, et al.
Published: (2009-01-01)